Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FHJW6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,584.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The delivery order, issued on December 18, 2025, with an ultimate completion date of January 12, 2026, carries no set-aside designation and was issued under the company's existing Indefinite Delivery Contract with DLA. This delivery order represents a single procurement action under DMS Pharmaceutical Group's broader pharmaceutical supply relationship with the federal government.
DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs of Department of Defense healthcare facilities worldwide. The company's primary IDC, valued at $499.9 million with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables. Stelara, an immunosuppressant biologic agent, falls within the company's established product portfolio and reflects DMS Pharmaceutical Group's role as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FHJW6?
SPE2DR26FHJW6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FHJW6 worth?
The government has obligated $16,584 on SPE2DR26FHJW6.
Is contract SPE2DR26FHJW6 an order under another contract?
Yes. SPE2DR26FHJW6 is a delivery order under SPE2DR25D9218, an indefinite delivery contract.
Was contract SPE2DR26FHJW6 competed?
The extent of competition for SPE2DR26FHJW6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award